Making clinical sense of the explosion in biologics - which drug for which patient and why?

V. Backer (Copenhagen, Denmark)

Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Session: PG10 Severe asthma in adults: systematic assessment and biological treatment
Session type: Postgraduate Course
Number: 16
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Backer (Copenhagen, Denmark). Making clinical sense of the explosion in biologics - which drug for which patient and why?. International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016


Telemonitoring in clinical practice: a way forward?
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013


Your new BT service - Making it happen
Source: International Congress 2014 – Bronchial thermoplasty: clinically proven long-term safety and efficacy in severe asthma
Year: 2014

Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018


"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

ACCP1 - Is telemedicine in your future?
Source: Annual Congress 2008 - MP17 - ACCP: Is telemedicine in your future?
Year: 2008

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited
Source: Eur Respir J 2016; 47: 664-667
Year: 2016


Anti-IgE: changing lives in clinical practice?
Source: Eur Respir Rev 2007; 16: 59-60
Year: 2007


Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016

Monitoring at home - telemedicine, how and why?
Source: Annual Congress 2004 - PG21 - Home mechanical ventilation in COPD patients
Year: 2004


Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018


What do we need from our patients? - the clinician's point of view
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014




The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


What's new in the management of CAP?
Source: Annual Congress 2012 - New guidelines in respiratory infections
Year: 2012


The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017